English English Verified botanical extracts, fat-soluble vitamins, and marine lipid oils calibrated for high stability in functional foods, feed premixes, and nutraceutical formulations.
A comprehensive examination of bacterial fermentation, all-trans stereochemistry, microencapsulation matrix technology, and pharmacokinetic superiority.
Menaquinone-7 (MK-7) contains seven isoprenoid units linked to a 2-methyl-1,4-naphthoquinone core. The biological efficacy depends strictly on the All-Trans geometrical isomer.
Cis-isomers, often produced as unmonitored byproducts in lower-grade chemical synthesis, lack biological stereocenter compatibility with gamma-glutamyl carboxylase (GGCX). BKYULA Biotech utilizes proprietary non-GMO Bacillus subtilis var. natto fermentation paired with selective supercritical CO2 extraction and dual-stage chromatography, ensuring a certified all-trans content >99.0% analyzed via validated reverse-phase HPLC.
While Vitamin K1 and menaquinone-4 (MK-4) display clear elimination half-lives of approximately 1.5 to 3 hours, our fermentation-derived MK7 demonstrates an extended serum clearance half-life of 72 hours.
This prolonged circulatory residence permits steady tissue distribution to peripheral vascular smooth muscle cells and osteoclasts. Lower daily dosing (75–180 mcg) achieves constant carboxylation of both Osteocalcin and Matrix Gla Protein (MGP), eliminating the cyclical serum troughs inherent to short-chain menaquinones.
Unprotected menaquinone degrades rapidly in the presence of alkaline mineral salts, including calcium carbonate, calcium citrate, and magnesium oxide.
Our microencapsulated powder utilizes a cross-linked polysaccharide and spray-chilled vegetable lipid wall. This physical barrier preserves potency under accelerated ICH stability conditions (40°C ± 2°C / 75% RH ± 5% RH), maintaining over 95% assay retention at 24 months even when combined with aggressive reactive minerals.
Optimizing formulation compliance with TR CU 021/2011, TR CU 027/2012, and Eurasian registration frameworks for pharmaceutical, dairy, and feed industries.
Belarus operates as a premier dairy producer within the CIS and Eastern European trade corridor. Major industrial dairy hubs in Minsk, Brest, and Grodno process millions of tons of milk, butter, and cheese annually.
Our water-dispersible and oil-soluble Vitamin K2 MK7 concentrates enable dairy processors to engineer premium functional milk powders, therapeutic cheeses, and fortified baby foods. These formulations activate calcium-binding proteins without affecting organoleptic profiles, odor, or coagulation properties during high-temperature short-time (HTST) pasteurization.
Demographic trends in Belarus reflect an aging demographic where cardiovascular calcification and osteopenia place severe strains on public health infrastructure.
Pharmaceutical compounding enterprises, such as those situated within the Great Stone Industrial Park, are rapidly formulating synergistic Vitamin D3 + K2 MK7 softgels and effervescent tablets. By routing systemic calcium directly into skeletal structures, K2 MK7 actively prevents vascular medial calcification, addressing localized preventive health objectives.
Belarus's intensive livestock and poultry agricultural sector requires advanced feed solutions compliant with FAMI-QS guidelines.
Sub-clinical skeletal fragility and tibial dyschondroplasia in rapid-growth poultry generate tangible economic losses. Supplementing standard feed premixes with microencapsulated MK7 optimizes bone mineral density, reduces embryonic mortality in breeders, and improves eggshell thickness under high-throughput agricultural conditions.
Standardized chemical and analytical specifications for pharmaceutical, nutritional, and industrial manufacturers.
| Grade Classification | Assay (HPLC) | Carrier / Matrix | Bulk Density | Key Application |
|---|---|---|---|---|
| K2 MK7 Fermentation Powder (Standard) | 0.2% (2,000 ppm) – 1.0% (10,000 ppm) | Maltodextrin / Acacia Fiber | 0.45 – 0.65 g/mL | Standard dietary capsules, dry-blend fortified shakes. |
| K2 MK7 Microencapsulated (Protected) | 1,000 ppm – 5,000 ppm | Modified Starch / Vegetable Wax | 0.50 – 0.70 g/mL | Multi-mineral tablets containing high-alkaline Calcium/Magnesium. |
| K2 MK7 Water-Dispersible Powder | 0.1% – 0.5% | Emulsified Plant Polysaccharides | 0.40 – 0.55 g/mL | Clear RTD beverages, rehydration sachets, liquid dairy fortification. |
| K2 MK7 Pure Crystal (API Grade) | ≥ 98.0% (All-Trans) | Direct Pure Active Compound | 0.30 – 0.45 g/mL | Pharmaceutical synthesis, masterbatch oily carrier dilutions. |
Built upon 15 years of chemical extraction and bioprocess synthesis experience. Verified onsite by SGS Group.
Our quality management framework is fully certified under ISO 9001:2015, ISO 22000, and HACCP. To serve multi-market global regulatory frameworks, our specialized facilities maintain active HALAL, KOSHER, and FAMI-QS registrations, accompanied by onsite SGS supplier verification.
Every commercial production batch undergoes mandatory analytical release through dual-system High-Performance Liquid Chromatography (HPLC), UV spectrophotometry, loss-on-drying evaluation, ICP-MS heavy metal detection, and microbiological culture counting. Certified COAs accompany each shipment without exception.
We accommodate both small-scale pilot R&D trials (MOQ from 1 kg; high-value compounds from 1 g) and full-scale industrial procurement. Comprehensive custom blending, particle sizing down to 120 mesh, premix compounding with Vitamin D3, and full OEM packaging are executed under cleanroom conditions.
Crucial commercial, regulatory, and logistics details addressing technical procurement into Minsk and the Eurasian economic zone.
Contact our technical applications team today. Receive comprehensive HPLC chromatograms, assay profiles, and quotation benchmarks within 24 hours.
